| Description |
| Product Type |
Product Size |
| Tablets |
14'S |
| Product Company |
| Searle Pharma |
Methyldopa 250mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Wilson Pharmaceuticals |
Amlodipine besylate 10mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Topotecan 4mg/4ml
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Mass Pharma |
Amlodipine 5mg
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Content | Extor Tablets are effective for lowering blood pressure. A condition known as hypertension (high blood pressure) can occur in some individuals due to various causes such as genetics, diabetes, heart diseases, etc.
| Amlodipine is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years and older. It is also used to treat certain types of angina (chest pain) and coronary artery disease (narrowing of the blood vessels that supply blood to the heart) | Topotecan is an antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer.
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Reviews
There are no reviews yet.